HK1210954A1 - Antibacterial compounds - Google Patents

Antibacterial compounds

Info

Publication number: HK1210954A1
Authority: HK; Hong Kong
Prior art keywords: antibacterial compounds; antibacterial; compounds
Prior art date: 2012-12-21

Application number

HK15111776.0A

Other languages

English (en)

Chinese (zh)

Inventor

Jrme Mile Georges Guillemont

Magali Madeleine Simone Motte

Anil Koul

Nacer Lounis

Original Assignee

Janssen Sciences Ireland Uc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-21

Filing date

2015-12-01

Publication date

2016-05-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47519922&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210954(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-12-01 Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc

2016-05-13 Publication of HK1210954A1 publication Critical patent/HK1210954A1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Thiazole And Isothizaole Compounds (AREA)

HK15111776.0A 2012-12-21 2015-12-01 Antibacterial compounds HK1210954A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12199026		2012-12-21
PCT/EP2013/077565 WO2014096300A2 (fr)	2012-12-21	2013-12-20	Composés antibactériens

Publications (1)

Publication Number	Publication Date
HK1210954A1 true HK1210954A1 (en)	2016-05-13

Family

ID=47519922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK15111776.0A HK1210954A1 (en)	2012-12-21	2015-12-01	Antibacterial compounds

Country Status (22)

Country	Link
US (3)	US9428474B2 (fr)
EP (1)	EP2934498B1 (fr)
JP (1)	JP6441229B2 (fr)
KR (1)	KR102233199B1 (fr)
CN (1)	CN104981238B (fr)
AP (1)	AP2015008503A0 (fr)
AU (1)	AU2013366572B2 (fr)
BR (1)	BR112015014145B1 (fr)
CA (1)	CA2892899C (fr)
CL (1)	CL2015001781A1 (fr)
EA (1)	EA038333B1 (fr)
ES (1)	ES2659953T3 (fr)
HK (1)	HK1210954A1 (fr)
MX (1)	MX2015008036A (fr)
MY (1)	MY173280A (fr)
NZ (1)	NZ708742A (fr)
PE (1)	PE20151165A1 (fr)
PH (1)	PH12015501428B1 (fr)
SA (1)	SA515360628B1 (fr)
SG (1)	SG11201504873RA (fr)
UA (1)	UA117672C2 (fr)
WO (1)	WO2014096300A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA038333B1 (ru) *	2012-12-21	2021-08-11	Янссен Сайенсиз Айрлэнд Юси	Антибактериальные соединения
US9801909B2 (en)	2015-04-06	2017-10-31	The Penn State Research Foundation	Compositions and methods for combating bacterial infections by killing persister cells with mitomycin C

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE744970A (fr)	1969-01-28	1970-07-27	Lilly Co Eli	Agents antiviraux et immuno-depresseurs
US4028374A (en)	1975-11-03	1977-06-07	Morton-Norwich Products, Inc.	Antibacterial thiocyanatobenzothiazoles
GB8816519D0 (en) *	1987-07-23	1988-08-17	Ici Plc	Antibiotic compounds
GB9107341D0 (en) *	1991-04-08	1991-05-22	Ici Plc	Antibiotic compounds
WO2000056725A1 (fr) *	1999-03-19	2000-09-28	Du Pont Pharmaceuticals Company	N-adamant-1-yl-n'-[4-chlorobenzothiazol-2-yl] uree utilisee dans le traitement des inflammations et comme agent de radiosensibilisation anticancereux
PT2301544E (pt)	2002-07-25	2012-12-10	Janssen Pharmaceutica Nv	Novos inibidores de micobactérias
NZ543372A (en)	2003-05-30	2008-11-28	Hoffmann La Roche	Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenoside A2A receptor
CA2572750A1 (fr)	2003-09-10	2005-03-17	Anil Koul	Composes heterobicycliques en tant qu'agents actifs au niveau pharmaceutique
EP1680431A1 (fr)	2003-10-17	2006-07-19	Rigel Pharmaceuticals, Inc.	Compositions de benzothiazole et de thiazole'5,5-b!pyridine et leur utilisation comme inhibiteurs de l'ubiquitine ligase
EP2024349B1 (fr)	2006-05-31	2017-08-02	AbbVie Inc.	Composés constituant des ligands de récepteurs cannabinoïdes et utilisations de ces composés
GB0724342D0 (en)	2007-12-13	2008-01-30	Prolysis Ltd	Anitbacterial compositions
EA038333B1 (ru)	2012-12-21	2021-08-11	Янссен Сайенсиз Айрлэнд Юси	Антибактериальные соединения

2013
- 2013-12-20 EA EA201591192A patent/EA038333B1/ru unknown
- 2013-12-20 PE PE2015001057A patent/PE20151165A1/es active IP Right Grant
- 2013-12-20 JP JP2015548614A patent/JP6441229B2/ja active Active
- 2013-12-20 US US14/654,186 patent/US9428474B2/en active Active
- 2013-12-20 MX MX2015008036A patent/MX2015008036A/es unknown
- 2013-12-20 AU AU2013366572A patent/AU2013366572B2/en active Active
- 2013-12-20 ES ES13814926.5T patent/ES2659953T3/es active Active
- 2013-12-20 AP AP2015008503A patent/AP2015008503A0/xx unknown
- 2013-12-20 SG SG11201504873RA patent/SG11201504873RA/en unknown
- 2013-12-20 NZ NZ708742A patent/NZ708742A/en not_active IP Right Cessation
- 2013-12-20 CN CN201380067207.4A patent/CN104981238B/zh active Active
- 2013-12-20 KR KR1020157018199A patent/KR102233199B1/ko active IP Right Grant
- 2013-12-20 BR BR112015014145-5A patent/BR112015014145B1/pt active IP Right Grant
- 2013-12-20 CA CA2892899A patent/CA2892899C/fr active Active
- 2013-12-20 MY MYPI2015001584A patent/MY173280A/en unknown
- 2013-12-20 UA UAA201507312A patent/UA117672C2/uk unknown
- 2013-12-20 EP EP13814926.5A patent/EP2934498B1/fr active Active
- 2013-12-20 WO PCT/EP2013/077565 patent/WO2014096300A2/fr active Application Filing
2015
- 2015-06-18 SA SA515360628A patent/SA515360628B1/ar unknown
- 2015-06-19 PH PH12015501428A patent/PH12015501428B1/en unknown
- 2015-06-19 CL CL2015001781A patent/CL2015001781A1/es unknown
- 2015-12-01 HK HK15111776.0A patent/HK1210954A1/xx unknown
2016
- 2016-08-08 US US15/231,389 patent/US9758497B2/en active Active
2017
- 2017-09-08 US US15/699,770 patent/US9951032B2/en active Active

Also Published As

Publication number	Publication date
SA515360628B1 (ar)	2017-05-18
MY173280A (en)	2020-01-10
AP2015008503A0 (en)	2015-06-30
PH12015501428A1 (en)	2015-09-07
BR112015014145B1 (pt)	2020-12-29
UA117672C2 (uk)	2018-09-10
US9428474B2 (en)	2016-08-30
EA038333B1 (ru)	2021-08-11
NZ708742A (en)	2020-06-26
JP6441229B2 (ja)	2018-12-19
MX2015008036A (es)	2015-10-29
AU2013366572B2 (en)	2018-08-30
CL2015001781A1 (es)	2015-11-06
CN104981238A (zh)	2015-10-14
PH12015501428B1 (en)	2015-09-07
SG11201504873RA (en)	2015-07-30
ES2659953T3 (es)	2018-03-20
CN104981238B (zh)	2019-05-31
JP2016503776A (ja)	2016-02-08
US20150344449A1 (en)	2015-12-03
US20160347728A1 (en)	2016-12-01
US20170369457A1 (en)	2017-12-28
CA2892899C (fr)	2021-07-20
BR112015014145A2 (pt)	2017-07-11
US9951032B2 (en)	2018-04-24
AU2013366572A1 (en)	2015-06-04
EA201591192A1 (ru)	2015-11-30
EP2934498B1 (fr)	2017-11-15
WO2014096300A3 (fr)	2014-08-14
KR102233199B1 (ko)	2021-03-30
CA2892899A1 (fr)	2014-06-26
US9758497B2 (en)	2017-09-12
KR20150099772A (ko)	2015-09-01
PE20151165A1 (es)	2015-08-19
WO2014096300A2 (fr)	2014-06-26
EP2934498A2 (fr)	2015-10-28

Publication	Publication Date	Title
HRP20181889T1 (hr)	2019-01-11	Spojevi tetrahidropirazolopirimidina
HK1245780B (zh)	2020-01-17	咪唑並吡咯烷酮化合物
EP2925129A4 (fr)	2016-06-08	Composés pro-neurogènes
GB201209138D0 (en)	2012-07-04	Compounds
GB201214750D0 (en)	2012-10-03	Compounds
GB201215357D0 (en)	2012-10-10	Compounds
EP2887803A4 (fr)	2016-08-03	Composés pro-neurogéniques
HK1206726A1 (en)	2016-01-15	Imidazotriazinone compounds
HK1206031A1 (en)	2015-12-31	Antibacterial compounds
GB201204985D0 (en)	2012-05-02	Compounds
GB201204125D0 (en)	2012-04-25	Compounds
EP2763539A4 (fr)	2015-04-15	Composés antibactériens
HK1211283A1 (en)	2016-05-20	Compounds
GB201209096D0 (en)	2012-07-04	Compounds
HK1212677A1 (zh)	2016-06-17	新型抗細菌化合物
HK1206356A1 (en)	2016-01-08	Lpar - substituted cyanopyrazole compounds lpar-
GB201219820D0 (en)	2012-12-19	Compounds
GB201217310D0 (en)	2012-11-14	Compounds
HK1210954A1 (en)	2016-05-13	Antibacterial compounds
GB201211202D0 (en)	2012-08-08	Antimicrobial compounds
IL239207A0 (en)	2015-07-30	Antibacterial compounds
GB201211203D0 (en)	2012-08-08	Antimicrobial compounds
GB201223429D0 (en)	2013-02-06	Compounds
GB201220029D0 (en)	2012-12-19	Compounds
GB201219819D0 (en)	2012-12-19	Compounds